BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCreadie, R. G.
Right arrow Articles by Heykants, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCreadie, R. G.
Right arrow Articles by Heykants, J. J.

The British Journal of Psychiatry 137: 510-517 (1980)
© 1980 The Royal College of Psychiatrists

Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia

RG McCreadie, JM Dingwall, DH Wiles and JJ Heykants

In a double-blind trial, 34 male chronic schizophrenic day-patients or in-patients in a hostel ward continued on fluphenazine decanoate given mostly once fortnightly or were switched to pimozide, given on four days each week. Over nine months relapse rates were similar for both groups, and while fewer patients on pimozide were prescribed antiparkinsonian drugs one quarter developed buccolingual masticatory dyskinesia. Plasma pimozide levels suggested satisfactory drug compliance. Average plasma prolactin levels were within the normal rage for untreated men in one quarter of non-relapsing patients on pimozide and three quarters on fluphenazine.


This article has been cited by other articles:


Home page
 FocusHome page
N. R. Schooler
Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Focus, January 1, 2004; 2(1): 175 - 186.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
D. V. Jeste and R. Jed Wyatt
Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience
Arch Gen Psychiatry, July 1, 1982; 39(7): 803 - 816.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1980 The Royal College of Psychiatrists.